Hyberbaric oxygen therapy claims, under CMS’ gaze, seesaw between 2015 and 2018
Medicare claims data for non-emergent hyperbaric oxygen (HBO) therapy and the introduction of a prior authorization model to support the procedure disclosed numbers that show the CMS program is working as intended — to curtail overuse.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.